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Abstract: MicroRNAs (miRNAs) are small non-coding RNA molecules of 21?23 
nucleotides that control gene expression at the post-transcriptional level. They have been 
shown to play a vital role in a wide variety of biological processes and dysregulated 
expression of miRNAs is observed in many pathologies. Understanding the mechanism of 
action and identifying functionally important mRNA targets of a specific miRNA are 
essential to unravelling its biological function and to assist miRNA-based drug 
development. This review summarizes the current understanding of the mechanistic aspects 
of miRNA-mediated gene repression and focuses on the different approaches for miRNA 
target identification that have been proposed in recent years. 
Keywords: miRNA; gene expression; miRISC; miRNA target identification; RIP-Seq; 
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1. Introduction 
MiRNAs are a large family of ~22 nucleotide RNAs which regulate virtually every aspect of 
biology, including development, proliferation, differentiation and metabolism [1]. It is therefore not 
surprising that disruption of miRNA function contributes to many human diseases, including 
cardiovascular disorders, cancer and complex genetic diseases [2?4]. 
MiRNAs are processed from precursor molecules (pri-miRNAs) which are normally transcribed by 
RNA polymerase II [5]. In animals, the majority (80%) of miRNA genes are located in introns of both 
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protein-coding and non-coding genes [6]. Thus, expression of a large subset of mammalian miRNAs 
may be transcriptionally linked to the expression of other genes, allowing for co-ordinate regulation of 
miRNA and protein expression [7]. The pri-miRNA is processed into the mature miRNA in a two-step 
manner. Briefly, in the nucleous, the RNAse III enzyme DROSHA, in complex with other proteins 
such as DGCR8 in mammals, cleaves the pri-miRNA into a ~70 nucleotide precursor (pre-miRNA) 
which is transported to the cytoplasm by exportin 5. Once in the cytoplasm, the pre-miRNA is further 
processed by another RNAse III enzyme?DICER, acting in conjunction with the RNA binding 
protein TRBP in mammals. As a result of this second cleavage a small RNA duplex (~20 nucleotides) 
is generated. In general, one of the strands (known as the guide) is incorporated into a miRNA-induced 
silencing complex (miRISC) while the other one (passenger strand) is released and degraded [8]. 
Further studies have confirmed that, in some cases, the passenger strand can also be loaded into 
miRISC, thus also functioning as a mature miRNA [9]. 
The core of miRISC is formed by the Argonaute (Ago) proteins. Different members of this family 
have specific expression patterns, binding partners and biochemical capabilities [10]. Indeed only 
Ago2 (out of the four Ago proteins expressed in humans) is capable of mediating endonucleolytic 
cleavage of the target mRNA which occurs when there is complete complementarity between a 
miRNA and a target site [11]. Nevertheless, most metazoan miRNAs direct RISC to their target 
mRNAs by interacting with sites of imperfect complementarity. As a result, the miRNA promotes  
the degradation and/or inhibits the translation of the target mRNA, resulting in repression of its 
expression [12]. 
In general, the most important region for target recognition comprises nucleotides 2?8 of the 
miRNA ????????????????????????????? and binding sites are most commonly found in the 3' UTR of 
the cognate mRNAs [13]. Despite this, many examples have emerged recently showing that miRNA 
binding sites can be located outside the 3' UTR (commonly in the coding region), and even lack of 
perfect seed pairing can sometimes be compensated by 3' complementarity or centered pairing [14?16]. 
Thus, predicting whether a mRNA will be regulated by a given miRNA in the endogenous context is 
challenging and gets more complicated still when taking into account the different factors that can also 
control the ability of a miRISC to bind and repress specific targets [17,18]. 
During the last decade, several bioinformatic tools have been developed to predict miRNA  
targets [19]. Algorithms are predominantly based on seed pairing and evolutionary conservation, 
typically predicting hundreds, even thousands of targets for each miRNA, including a high proportion 
of false-positives and false-negatives [20]. 
The difficulty and complexity of identifying endogenous miRNA targets has resulted in the 
generation of a wide variety of experimental approaches, from identification of mRNAs/proteins 
regulated by overexpressing or antagonizing a given miRNA to genome-wide approaches including 
immunoprecipitation of miRISC [21]. In this review, we first briefly present the molecular 
mechanisms that drive miRNA silencing. Next we summarize the bioinformatic tools currently 
available for miRNA target prediction and finally we discuss in detail the different experimental 
approaches that have been undertaken in recent years, paying special attention to their potential 
limitations for identifying biologically relevant targets. 
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2. Mechanisms of miRNA Repression 
The exact mechanisms used by miRNAs to regulate gene expression remain unclear and have been 
a controversial subject in recent years. Evidence for translational repression, mRNA destabilization 
and even activation of gene expression has been reported [22]. 
Initial work in animals pointed to regulation at the level of mRNA translation. Translation in 
mammals requires numerous factors that allow the recruitment of the ribosomal subunits to the mRNA 
initiation codon (initiation), the elongation of the nascent polypeptide chain (elongation) and  
the release of the mature protein (termination). Some of these factors recognize the 5' Cap or the  
3' UTR tail of the mature mRNAs allowing its efficient translation [23]. Although most of the  
studies pointed to miRNAs as inhibitors of mRNA translation initiation [24,25], inhibition of 
elongation, premature termination of translation and co-translational protein degradation have also 
been described [22,26?29]. 
Whereas perfect pairing of an entire miRNA with its target resulting in endonucleolytic cleavage is 
a rare mechanism in animals, exonucleolytic degradation often occurs. Thus miRNAs promote the 
recruitment of deadenylation factors to the target mRNA which remove its poly(A) tail making the 
mRNA more susceptible to exonucleolytic degradation. Indeed, recent work shows that binding  
of some of these factors, such as CCR4-NOT promotes deadenylation to repress translational  
initiation [30,31]. 
Several groups have taken advantage of advances in mass spectrometry and RNA sequencing to 
study, on a genome-wide scale, the effects of miRNA action on mRNA and protein levels after 
miRNA ectopic expression or removal in animals [32,33]. Although, in general, these studies conclude 
that degradation of miRNA targets is a widespread effect of miRNA action and provides a major 
contribution to silencing by animal miRNAs [34], whether target degradation occurs as a consequence 
of an initial block in translation remains an unresolved question. The fact that some authors have found 
hundreds of miRNA targets for which protein levels were decreased far more than mRNA levels [35] 
supports the idea that the precise mechanism of action is highly cell type and/or target-specific 
dependant. The effects of miRNAs on both plant and animal mRNA translation and decay have been 
comprehensively reviewed elsewhere [12,22,36]. 
3. Computational miRNA Target Identification 
The best characterized features determining miRNA-target recognition are six-nucleotide (nt) seed 
binding sites, which perfectly complement the 5' end of the miRNA (positions 2?7) [13]. Also, a match 
with miRNA nucleotide 8, an A across from nucleotide 1, or both of these conditions, augment the 
seed pairing and enforce miRNA-mediated repression [37]. These seed-pairing ?rules? are widely used 
to predict functional miRNA target-sites, normally in combination with the secondary structure of the 
3' UTR, the neighbouring contextual information and/or evolutionary conservation [13,38,39]. It has 
been recently shown that miRNAs can also effectively repress the expression of their targets through 
??-??????? ?????????????? ???????? ???-bulge in position 5?6 of the seed-complementary region [40]. 
Based on that, in recent years several miRNA target prediction programs have been published [20,41] 
with characteristic features summarized in Table 1. 
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Table 1. Characteristic features of the most commonly used programs for prediction of miRNA targets. 
Program Reference Detection capacity Seed-match Allows mismatches 
Sequence 
analyzed in 
target 
Thermodynamics 
and/or secondary 
structure of the duplex 
Conservation 
Considers non-
conservative sites 
Additional features 
DIANA-microT  [42] 
mRNA targets for a given 
miRNA; miRNAs targeting a 
given mRNA; Specific 
miRNA/mRNA interactions  
7?9 nt long  
Additional 3' pairing; single 
G:U wobble pair; 6 nt seed  
3' UTR  +  +  +  
Signal to noise ratio and 
precision score for evaluation of 
significance  
DIANA-microT-CDS [43] 
mRNA targets for a given 
miRNA; miRNAs targeting a 
given mRNA; Specific 
miRNA/mRNA interactions  
7?9 nt long  
Additional 3' pairing; single 
G:U wobble pair; 6 nt seed  
3' UTR + CDS  +  +  +  
Signal to noise ratio and 
precision score for evaluation of 
significance  
microInspector  [44] 
miRNAs targetting a given 
mRNA; Specific 
miRNA/mRNA interactions  
6 nt long  
4?5 nt seed with additional 
G:U pair  
ANY (submitted 
by the user)  
+  
  
Allows identification of weak 
interactions in any reagion of the 
mRNA  
miRanda  [45] 
mRNA targets for a given 
miRNA; miRNAs targeting a 
given mRNA; Specific 
miRNA/mRNA interactions  
Positions 2?8 
given higher 
weigth  
Some mismatches allowed  3' UTR  +  + (PhastCons score) +  
MicroRNA expression profile 
available. mirSVR score 
available  
Pictar  [46] 
mRNA targets for a given 
miRNA; miRNAs targetting a 
given mRNA  
7 nt  
Single G:U wobble pair 
allowed  
3' UTR  +  +  
 
Accounts for synergistic effects 
of several miRNAs/same miRNA 
binding  
RNA22  [47] 
mRNA targets for a given 
miRNA; miRNAs targeting a 
given mRNA; Specific 
miRNA/mRNA interactions  
6?7 nt  Optional 1?2 mismatches  
ANY (submitted 
by the user)  
+  
  
Permits identification of binding 
sites even if the miRNA is 
unknown  
RNAhybrid  [48] 
Specific miRNA/mRNA 
interactions  
Optional  Optional  
ANY (submitted 
by the user)  
+  
  
Variation of secondary structure 
prediction, seed is given little 
weigth  
TargetScan (v6)  [49] 
mRNA targets for a given 
miRNA; miRNAs targeting a 
given mRNA; Specific 
miRNA/mRNA interactions  
6?7 nt (+ A in 
position 1)  
Allowed if compensation 
by conserved 3' pairing  
3' UTR  +  +  
+ (very low 
scores)  
Importance of the context score: 
local AU content, position in the 
3' UTR, site abundance.  
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Additional information resources record nomenclature, sequence annotation such as genomic 
organization, precursor sequences, literature citations and links to target prediction sites (miRBase [50]; 
miRGen [51]), experimentally validated microRNA targets (TarBase [52]) or microRNA expression 
profiles (miRNAMap [53]; smiRNAdb). 
The fact that animal miRNAs have only limited complementarity to their target sites means that 
even small differences in algorithms used produce a big difference in target predictions. Although the 
common assumption that targets predicted by more than one program are more accurate, this does not 
appear to be the case. A few recent papers have performed very interesting studies where miRNA 
binding sites predicted by different algorithms were tested against genes proposed as targets by 
experimental evidence [20,54]. The major conclusion of such studies was that, in general, programs 
that rely on evolutionary conservation of the mRNA sequence complementary to the seed tend to have 
relatively high precision but low sensitivity. The same occurs when a combination of algorithms is 
used: better specificity is achieved at the cost of reduced sensitivity. In practice, this yields a very good 
performance of these bioinformatics tools for prediction of highly conserved consensus binding sites 
(an accuracy of ~50% in many cases [20]) but a very low efficiency for the detection of non-conserved 
binding sites, as well as for those binding sites with poor pairing in the seed sequence. Similarly, one 
of the biggest limitations of current algorithms is that the predictions are in most cases restricted to the 
3' UTRs, when recent experimental data indicate that a large proportion of the miRNA/mRNA 
interactions may occur through the coding sequences (CDS) or even the 5' UTR [16]. In addition, the 
binding rules for miRNA/target interactions through the 3' UTR could be different than through other 
mRNA regions, further reducing the capacity of current logarithms to predict these interactions. 
Finally, none of these methods takes into account the possibility of tissue-specific interactions. 
Thus, experimental approaches for miRNA target determination are not only indispensable to confirm 
the biologically relevant targets of a given miRNA but are also essential to uncover further rules (both 
general and specific) of miRNA target binding. In this way, experimentally-based (and validated) data 
will feed back to significantly improve and refine the performance of computational predictions of 
miRNA-target interactions. 
4. Experimental miRNA Target Identification 
Although many miRNAs and their binding sites are highly conserved, suggesting an important 
function, a typical miRNA-target interaction produces only a subtle reduction (< 2 fold) in protein 
level of its target and many miRNAs can be inhibited or deleted without generating any obvious 
phenotype. Accordingly, an emerging view is that miRNAs may act to confer robustness to biological 
processes, for example, by reinforcing transcriptional programs to sharpen developmental transitions 
and entrench cellular identities or buffering fluctuations in gene expression, sharpening the cell 
response to stress signals or certain regulatory networks [55]. This does not make it any easier to 
identify the relevant targets of a given miRNA. Indeed, when bioinformatics tools have been used to 
pre-select the putative targets of a given miRNA, the vast number of predicted targets (usually with 
very disparate functions and including a high percentage of false-positives and false-negatives) 
challenges scientists to choose which ones are worthy to validate experimentally, and which ones will 
have a major impact in a given biological process under study. Although methods for target validation 
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will also be discussed in this section, we will first focus on those experimental approaches that allow 
the researcher to directly determine the actual targets in a specific biological system, avoiding the 
biases inherent in the use of computational predictions. 
High-throughput methods for identifying miRNA targets have been developed using a wide variety 
of experimental technologies, normally in combination with overexpression/inhibition of the miRNA, 
and in some cases with biochemical isolation of target mRNAs that are bound to miRNAs [56]. 
4.1. Expression Profiling Following miRNA Overexpression/Inhibition 
Since microRNAs act by inhibiting translation and/or promoting degradation of their targets, the 
most straight-forward approaches rely on transfection of specific miRNA mimics or inhibitors into the 
cells followed by high-throughput analysis of mRNA expression (by microarray or high-throughput 
sequencing (HT-Seq), or proteomics [57]. 
Initial studies transiently transfected miR-1 (muscle-specific) and miR-124a (brain-specific) into 
Hela cells, where they are not normally expressed, and used microarray analysis to identify those 
mRNAs downregulated as a consequence [58]. Similar studies where soon performed [37,59] showing 
that mRNA transcripts downregulated after miRNA overexpression were significantly enriched for 
matches to the seed sequence. To avoid the bias that could be caused by the delivery of 
supraphysiological levels of an exogenous miRNA, the same kind of approach has been applied using 
antisense oligonucleotides that inhibit miRNA action [60], observing, for example, that a high number 
of transcripts were increased upon inhibition of miR-122 in the liver [61]. Despite the often beautiful 
work presented by these groups, introduction of miRNA inhibitors in primary cells or tissues is 
challenging (as is the inhibition of an endogenously highly expressed miRNA), and therefore most of 
the results have been obtained by overexpression of miRNAs in cell lines. Interestingly, when 
inhibition of miR-15 and miR-16 was performed in addition to overexpression experiments [59], the 
increase in mRNA expression after inhibition was small compared to the downregulation observed 
after overexpression. Thus, the effect of ectopic miRNAs might be easier to detect and therefore a 
more useful tool, although potentially more prone to artifacts. Technical advances in next-generation 
sequencing technology have now enabled the use of RNA-Seq as an alternative to microarray gene 
expression analysis, providing a larger list of inferred miRNA targets in over-expression studies [62]. 
The higher sensitivity of this technology may be especially useful when miRNA inhibition is 
performed, since small changes in RNA levels can be more reliably detected. 
The transcriptome profiling approach has two clear limitations: first, this method cannot distinguish 
direct from indirect targets (which can be partially minimized by harvesting the cells soon after 
transfection) and second, those targets that are only regulated at the level of translation, occurring 
without significant alteration of the transcript levels, will not be detected. This second handicap can be 
addressed by the use of proteomics. Proteomic approaches have the inherent advantage of assaying the 
ultimate effect of miRNAs. Newly synthetized proteins can be metabolically labelled by growing cells 
in medium containing heavy isotopes of essential amino acids (SILAC: Stable isotope labelling by 
amino acids in cell culture). Mass spectrometry can then be used to determine the ratio of peptide peak 
intensities from the light and heavy isotopes as a measurement of protein synthesis and the differences 
can be assessed after overexpression/inhibition of a given miRNA [35,63]. This approach was 
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successfully used, for example, to determine targets of (overexpressed) miR-1, miR-124 and miR-181 
in Hela cells and of miR-223 using mouse neutrophils isolated from miR-233 deficient mice [32], 
finding that, for most of the targets changes in mRNA transcript levels were also detected. A similar 
correlation has been detected in several other studies, as well as an enrichment in seed matching 
sequences in the detected targets [35,64]. 
4.2. Polysome Profiling Following miRNA Overexpression/Inhibition 
A mRNA that is being actively translated will be bound to a high density of ribosomes. 
Accordingly, a ribosome-profiling strategy is based on the recovery of the mRNA fragments that are 
bound by ribosomes (and thus protected from the action of RNAses), and identification of those 
fragments by deep sequencing. The abundance of different fragments corresponding to an mRNA is a 
direct indication of the amount of translation of that gene. [65]. This approach was used in 2010 by 
????????????????????????????????????????????????????????-1 or miR-155 in HeLa cells, which do not 
normally express these miRNAs [34]. They transfected HeLa cells with miR-155/miR-1 mimics and 
treated them with cycloheximide to arrest the translating ribosomes. Next, they digested the  
non-protected RNA with RNAseI and purified the resultant monosomes by a sucrose gradient. Those 
monosomes contained RNA fragments of ~30 nucleotides, which were released and identified by  
high-throughput sequencing (Ribosomal protected RNA fragments, or RPF). In parallel, total mRNA 
after miRNA overexpression was also sequenced to assess the contribution of mRNA stability  
(RNA-Seq) versus translational repression (RPF) with regard to the miRNA mechanism of action. The 
same experiment was performed with neutrophils obtained from a miR-223 knockout mouse versus 
wild-type, which express high levels of miR-223. They found that expression of genes with at least one 
predicted miR-155 or miR-1 binding site in their 3' UTR was lower after miR-155 or miR-1 
transfection in both RNA-Seq and RPF samples. Conversely, genes with at least one binding site for 
miR-223 were over-represented in RNA-Seq and RPF from miR-223 null neutrophils. By using this 
approach, the main finding of these authors was that at least 84% of the miRNA-mediated repression 
was due to mRNA destabilization, since only minor differences were found between the RPF (measure 
of translation) and the RNA-Seq (measure of RNA degradation) after miRNA modulation. Nevertheless, 
using a similar technique, Bazzani and co-workers [66] found that the effects of miR-430 in  
zebrafish occur at the level of translation preceding RNA decay, so this disparity may result from the 
steady-state conditions used, the biological system, or the miRNA under study. 
In general, it has been assumed that changes in mRNA levels closely reflect the impact of miRNAs 
on gene expression [34] and, given that proteomics approaches are more expensive, less sensitive and 
technically more complex than mRNA profiling techniques, it is not surprising that most of the 
publications generated are based on transcriptome analysis. Ribosomal profiling, on the other hand, is 
technically very challenging, and although a recently developed technique, the quick reduction in the 
cost of the HT-Seq makes it probable that this approach will be increasingly used in the future in 
combination with mRNA profiling. 
Nevertheless, importantly, none of these techniques allows distinction between direct and indirect 
targets, and, in addition to altered expression, candidate targets are normally selected based on 
(imperfect) computational predictions (as previously discussed). Therefore, during the last few years 
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efforts have been directed to the development of unbiased techniques to enable efficient and 
unambiguous determination of direct miRNA targets, i.e., those targets found in the cell specifically in 
association with the miRNA effector complex, i.e., miRISC. 
4.3. Pull-Down Assays with Members of miRISC 
The mammalian miRISC is the means by which mature miRNAs bind their mRNA targets, and they 
contain several proteins, including an AGO protein and GW182 [67,68]. Different methods have been 
developed to recover those mRNAs bound by miRISC (and therefore direct miRNA targets)  
using pulldown or immunoprecipitation of a component of miRISC (both a native member or an 
epitope-tagged one), normally in combination with overexpression/inhibition of the miRNA of 
interest. The recovered mRNAs can then be detected individually by RT-qPCR, or more commonly by 
high-throughput techniques such as microarrays or HT-Seq. 
4.3.1. Tagged miRNA Pull-Down 
Ørom and colleagues developed a direct affinity purification method for experimental identification 
of miRNA targets based on the transfection into cells of synthetic miRNA duplexes carrying a biotin 
group attached to the 3' end of the miRNA sense strand. These sense strands are incorporated into 
miRISC and, after cell lysis, the miRNA-mRNA complexes are captured on streptavidin beads from 
which the mRNA species can be purified and analysed [56]. This technique led to the discovery of 
miR-10a interaction with the 5' UTR of ribosomal protein transcripts which surprisingly enhanced 
their translation and independently demonstrated previously detected targets of miRNAs bantam and 
miR-124 in cell lines [69]. Nevertheless this study is rather controversial for several reasons: firstly, 
the pulled down mRNAs were not enriched for miR-10a seed matches; secondly, the fact that they 
were mostly abundant ribosomal mRNAs suggest they might have associated with the biotinylated 
mRNA non-specifically (it is not known what effect the biotin tag may have on miRNA binding); and 
finally, as already mentioned, most identified genes were translationally upregulated, rather than 
downregulated, which the authors attribute to the presence of binding sites in the 5' UTRs. Thus, the 
ability of this technique to comprehensively identify true miRNA targets has yet to be fully validated. 
An in vitro variation of this technique called LAMP (Labeled microRNA pull-down assay) utilizes 
digoxigenin (DIG)-labelled pre-miRNA oligonocleotides that are mixed with cell extracts. Labelled 
extracts are immunoprecipitated with anti-DIG antibodies before analysis of the co-immunoprecipitated 
mRNAs [70]. 
A recently developed alternative to biotin-labelling is so-called miR-TRAP (miRNA target affinity 
purification) in which the miRNA is conjugated to psoralen to produce a highly photo-reactive probe. 
The labelled miRNAs function similarly to endogenous miRNAs, and when the cells are exposed to 
UVA radiation (360 nM which is less harmful than the 254 nM used in other crosslinking 
experiments?a consideration relevant for in vivo experiments) the Pso moiety of the miRNA  
reacts with uridin on target mRNAs, enabling the bound complex to be stringently purified by  
biotin-streptavidin affinity purification. The biotin is incorporated in the 3' UTR of the miRNA as an 
affinity tag [71]. The authors have successfully used this approach to detect two novel targets of  
miR-15b and are currently applying these methods to assess miRNA targets in various disease models. 
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Although susceptible to the same handicaps as the more simply labelled biotinylated miRNA based 
technique, the covalent link between the Psoralen-tagged miRNAs and target mRNAs allows the use 
of much more stringent purification conditions, which may diminish the recovery of non-specific targets. 
Interestingly, all of these methods could be modified to identify miRNAs targeting a mRNA of 
interest by replacing labelled miRNA with labelled transcript. Along these lines Yoon and colleagues 
proposed a systematic approach termed MS2-TRAP (tagged RNA affinity purification) for identifying 
miRNAs associated with a target transcript in a cellular context. Briefly, they tagged the mouse 
linRNA-p21 with MS2 hairpins and co-expressed it in mouse embryonic fibroblasts (MEFs) along 
with the chimeric protein MS2-GST. They then affinity-purified the miRNAs present in the RNP 
complexes using glutathione-SH beads and finally measured them by qPCR. Out of the 5 miRNAs 
analysed (predicted to target linRNA-p21), 4 were enriched in the pulldown and two were functionally 
validated [72]. This approach could be widely used if coupling of the pulldown to high-throughput 
approaches for miRNA detection were performed. Nevertheless, one of its biggest limitations is that 
both the tagged RNA and the MS2-protein have to be exogenously introduced, which restricts its use 
to cell lines since there is typically low efficiency of transfection of such reagents in primary cells or in 
an in vivo setting. 
4.3.2. Immunoprecipitation of miRISC Proteins 
Regardless of subsequent mechanism of action, all miRNAs first bind to the target mRNAs in the 
miRISC. Different approaches have been developed in order to recover and detect those mRNAs  
co-immunoprecipitated with RISC proteins. To identify targets of specific miRNAs, cells are 
transfected with a synthetic miRNA or a miRNA inhibitor, versus a control. After incubation, cells are 
mildly lysed, miRISC complexes immunoprecipitated using antibodies against Ago2 or other members 
of miRISC and captured mRNA is isolated and quantified by microarray analysis or RNA-Seq. 
Directly bound targets of overexpressed miRNAs will thus be more abundantly detected (versus 
control), while the reverse is the case for targets of inhibited miRNAs. These high throughput methods 
are known as RIP-ChIP (Ribonucleoprotein Immunoprecipitation followed by microarray chip analysis) 
or RIP-Seq (Ribonucleoprotein Immunoprecipitation followed by High-throughput sequencing) [73,74]. 
Karginov and colleagues used microarrays to identify mRNA co-immunoprecipitated with  
c-myc-tagged-Ago2 that was stably transfected in 293S cells in combination with miR-124a mimics, 
detecting several targets that were affected by this miRNA only at the translational level [75]. Artifacts 
introduced by the use of epitope-tagged Agos (e.g., the possibility of unspecific association with RNA) 
can be eliminated by the precipitation of endogenous components of RISC. As an example, Tan and 
co-workers simultaneously inhibited four miRNAs (miR-17/20/93/106) in two different cell lines and 
performed immunoprecipitation of endogenous Ago2. The Ago2-associated (IP) transcripts were 
differentially detected by microarray as well as the transcripts present in total RNA fractions (T) of the 
extracts used for IP [76]. They identified more than two thousand mRNAs depleted in the IP fraction 
versus the total RNA (comparing IP/T ratio), and identified more than 100 candidates with a high 
enrichment in seed target sites in their 3' UTRs, supporting the suitability of this method to detect 
miRNA targets. In addition, they validated by luciferase assays all the targets assayed (nine that 
contained at least a 6-mer seed site for miR-17 from the list of top regulated genes), while the two 
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most potent targets assayed without a 6-mer site in the 3' UTR did not increase luciferase activity upon 
miR-17 inhibition. Although the presence of those transcripts in the IPs could be due to non-specific 
binding, the authors do not rule out the possibility that those transcripts may be targeted through  
the CDS. Immunoprecipitation with Ago1 has also been used to isolate targets in mammalian  
cells [67,77]. 
One obvious limitation of this procedure is that, in many cases, the use of antibodies against only 
one of the several Ago proteins [11] expressed in an organism is performed. Hypothetically, mRNAs 
and miRNAs pulled down with different Agos may not be identical, although so far a high extent of 
overlapping functions has been observed for the different Agos [78]. Antibodies that recognize all 
Agos present in the cells or other members of RISC could preferentially be used [79,80]. 
Although these approaches potentially identify direct miRNA targets, they do not give information 
about the precise binding site and they are normally combined with bioinformatic tools and 
experimental validations. On the other hand, these techniques require that the miRISC-mRNA binding 
is stable enough to survive the IP conditions and it is known that the quantities of recovered RNA are 
normally very low (especially when using primary cells as starting material). 
In order to stabilize the RNA-protein binding, allowing the capture of more transient interactions, 
the most recently developed techniques include the covalent UV-mediated cross-linking of the RNA to 
the proteins in situ preceeding lysis of the cells and the immunoprecipitation step. The first group to 
develop this technique for the identification of miRNA binding sites was the Darnell laboratory [81] 
and they termed it HITS-CLIP (High-throughput sequencing of RNAs isolated by crosslinking 
immunoprecipitation). The same group had previously used this technique for the identification of 
protein-RNA interactions in living tissues in a genome-wide manner [82]. Briefly, the method consists 
of the use of ultraviolet radiation to crosslink RNA-protein complexes that are, theoretically, in direct 
contact. The immunoprecipitation of miRISC can then be performed in much more stringent 
conditions (possibly decreasing the non-specifically bound material recovered). In addition, the 
unbound RNA is digested to leave miRISC-protected RNA fragments, which are analysed by HT-Seq. 
These fragments correspond to miRISC binding sites, so this technique enables mapping of the 
interaction sites. This first study not only elegantly proved that CLIP can be successfully used for 
mapping of miRISC positioning along the target mRNAs, but also made an important contribution to 
uncovering the mechanism governing miRNA-target recognition. A high percentage (25%) of the 
reads were mapped to open reading frames (ORFs), although the majority corresponded to 3' UTRs 
and only 1% to the 5' UTR, confirming that miRNAs preferentially bind their targets through the  
3' UTR but also highlighting the importance of CDS-mediated interactions. Furthermore they found 
that a high percentage of the mapped sites did not contain seed sequences for any of the most abundant 
miRNAs in the studied tissue (brain), indicative of seedless interactions. Indeed, another study from 
the same group proved an alternative binding mode used by miRNAs: mRNAs containing a G-bulge 
site after the five consecutive nucleotides in positions 2?6 comprised >15% of all Ago-miR-124-mRNA 
interactions in mouse brain, and more than 75% of the non-seed detected sites [40]. The authors also 
found that these sites are present both in the 3' UTR and in the coding region of the transcripts and the 
degree of miRNA-mediated repression is similar to that observed for canonical seed binding sites. 
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To our knowledge, this approach has only been used so far to identify genome-wide miRNA-RISC-
mRNA ternary complexes from a cell line or tissue but, its combination with over-expression/inhibition 
of a given miRNA could potentially be used to determine the targets of that specific miRNA. 
HITS-CLIP allows mapping of miRISC binding sites with a resolution of ~50 nucleotides [81], 
while a modification of this method, PAR-CLIP (Photoactivatable-Ribonucleoside-Enhanced Crosslinking 
and Immunoprecipitation) allows identification of the precise location of the crosslink [16]. This 
method uses 365 nm-UV light to induce efficient cross-linking of RNA-binding proteins with 
photoreactive ribonucleoside analogs (such as 4-thiouridine) that are incorporated into nascent mRNAs 
by living cells. When this is used in combination with Ago IP, miRNA-targets are isolated, fragmented 
and identified by HT-Seq. When the RNA contains 4-thiouridine, the crosslinking causes thymidine to 
cytidine transitions, which are detected as mutations during the deep-sequencing making it possible to 
separate them from the background and giving a much more accurate mapping [83]. Also, the 365 nm 
UV crosslinking proteins-photoreactive ribonucleoside analogs are more efficient than the 245 nm 
protein-RNA, thus improving the precipitated RNA yields. Similarly to Chi and colleagues, Hafner 
and co-workers found abundant miRNA binding sites in coding regions. 
These approaches may be useful not only to precisely map a direct interaction between a given 
miRNA and its targets, but also to detect those targets only affected at the level of translation or  
the interactions mediated by atypical binding sites. One disadvantage is that both PAR-CLIP and 
HITS-CLIP can present a selection bias for strong RNA-protein interactions, and highly expressed 
transcripts are generally over-represented [84]. In addition, these methods are technically extremely 
challenging, requiring the use of highly advanced technology not currently widely available and a very 
complex post-experimental (bioinformatics) analysis. Furthermore, the long multistep protocols 
normally require a very large amount of initial material, which is not possible in many cases, e.g., 
when using primary cells, and there may be potential difficulties in the combination of these 
approaches with the use of miRNA mimics/inhibitors. It is not surprising, then that only a few research 
groups are currently applying these techniques, although further optimization of the protocols may 
make them more accessible to other groups, which will in turn help with the validation of the 
technique and determination of its full applicability. 
5. Experimental Validation of miRNA Targets 
No matter how a miRNA-target interaction has been studied (bioinformatically or experimentally), 
it is essential to validate its functionality in the biological model of interest. 
Since an inverse relationship between the levels of expression of a miRNA and its target is 
anticipated, the most direct and straightforward method for validation consists in mimicking/inhibiting 
the miRNA of interest (as previously described, generally by transient transfection) and assessing the 
effect in the target gene expression. Since overexpression can lead to interactions not normally 
occurring in the cells, inhibition should give more physiologically relevant conclusions. Nonetheless it 
is not always easy to inhibit the action of a miRNA to a significant extent so overexpression is more 
commonly performed [85]. 
The analysis of the effect on target gene expression should be preferentially done at the protein 
level (normally by Western blotting, ELISA, immunostaining, etc.), although due to convenience and 
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reduced costs researchers often analyse changes in target mRNA levels instead. In that instance (as 
previously stated) an effect will only be observed if the miRNA affects the stability of the target, 
which does occur in many cases [34]. Messenger RNA changes are normally quantified by RT-qPCR, 
which requires low amounts of starting material and is quick and relatively cheap. Alternatively, 
Northern blotting can be useful, although time-consuming, especially in those cases where different 
isoforms of the target are expressed. 
Finally, reporter assays are universally used to confirm a direct regulation of gene expression by a 
miRNA [21]. Generally the 3' UTR of the transcript of interest is cloned downstream of a luciferase 
ORF. When this vector is transfected into cells expressing the targeting miRNA, luciferase activity 
should be lower than for the empty vector. Inhibition of the miRNA action by co-transfection of 
antagonists should then result in the recovery of the luciferase expression levels, confirming that the 
repression is specifically mediated by that miRNA. Nevertheless, in many cases, transcription from the 
promoter contained in the vector is too strong and the endogenous miRNA is not able to mediate a 
detectable repression. In such cases, co-overexpression of the miRNA is widely used. To corroborate 
the direct interaction, mutation of the anticipated miRNA-binding site/s is introduced in the reporter. 
This mutation is expected to eliminate (or at least reduce) any miRNA-mediated effect. 
Where the miRNA-target interaction is not mediated by the 3' UTR, but rather through the  
coding region, validation using reporter experiments can also be used, and the predicted binding site, 
together with the flanking sequences, may be cloned downstream of the luciferase coding region. 
Generally, sites in the coding region have a weaker effect on gene expression, thus their validation is 
more challenging. 
6. Conclusions 
Since discovered in 1993 [86], miRNAs have captured the attention of the scientific community. 
Nevertheless their specific functions in cells have barely begun to be unravelled. The rapid 
development of bioinformatics tools and HT-Seq techniques during recent years have led both to the 
discovery of many new miRNA classes in a multitude of different organisms and to the generation of a 
huge amount of data indicating their possible targets and mechanism(s) of action. Nevertheless only a 
small proportion of miRNA-target interactions have been functionally validated. Although each 
method presented here has important limitations, combining them wisely can lead to the identification 
of many biologically relevant targets which is essential for understanding miRNA function and for 
tapping their undoubted therapeutic potential. 
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